Thomas Marsden

Chief Executive Officer @Bioreg Life Sciences

Nottingham, GB
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Mar 2026 — Present

Chief Executive Officer @Bioreg Life Sciences

View department →

Nottingham, GB

EDUCATION

2003 — 2005

Hull College

BTEC National Diploma in Health Studies

2007 — 2008

Leeds Beckett University

Foundation degree, Public Health

2010 — 2013

University of Hull

BA Hons, Social Sciences

SKILLS

BusinessFda GmpDocumentumIch GuidelinesResearchDossier PreparationDossier PlanningLegal ResearchDatabase AdministrationFinancial AnalysisStrategyRolloutDclGmpRegulatory RequirementsDossier SubmissionHealthcareNeesCriminal JusticeInsight PublisherTdsRegulatory CompliancePharmaceutical IndustryFinancial ForecastingHealth Care ProfessionalsValidationData AnalysisProduct LaunchResearch AnalysisVariation AnalysisConsumer Goods IndustriesRegulatory SubmissionsPublic HealthRegulatory AffairsDistribution Center OperationsDocument Lifecycle ManagementPublic SafetyEctdRow

ABOUT THOMAS MARSDEN

I\'m Thomas Marsden, CEO of BioReg Life Sciences.My job is simple: help life sciences companies get their products to market. No delays. No avoidable rejections. No regulatory surprises.I\'ve spent over 20 years inside major CROs and global pharmaceutical companies, leading regulatory operations across the US, EU, China and global markets. I\'ve seen what works. I\'ve seen what fails. And I\'ve seen too many promising products delayed — not because the science was bad, but because the regulatory strategy was missing.That\'s why I created BioReg Life Sciences. How I lead:I believe that senior expertise should never be a hand-off. When you work with us, you work directly with me and Cheryl. No junior account managers. No layers. Just experienced regulatory professionals who take full ownership of your project.I lead by being accountable. If a submission is delayed, that\'s on me. If a client is confused, that\'s on me to fix. I don\'t hide behind processes or pass responsibility down the chain.How I help the industry:We provide end-to-end regulatory support for pharmaceutical, biotech, gene therapy and medical device companies — from Phase 2 through to market and beyond.That means:Regulatory strategy and market entry planningGap analysis and dossier preparation (M1 & M2)eCTD publishing and submission managementMarketing Authorisation Applications (MAA/NDA)Product lifecycle management and Brexit supportOne partner. Complete ownership. submissions. 100% acceptance rate.Why I do this:Because patients shouldn\'t have to wait longer than necessary for life-changing medicines. Because scientists should focus on science, not regulatory paperwork. And because the industry deserves a regulatory partner that actually delivers.If you\'re bringing a product to market — and you want a leader who will own the journey with you — let\'s talk.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Thomas Marsden — Chief Executive Officer at Bioreg Life Sciences in Nottingham, GB | Unifers